Adherence and medication utilisation patterns of fixed-dose and free combination of angiotensin receptor blocker/thiazide diuretics among newly diagnosed hypertensive patients: A population-based cohort study

International Journal of Clinical Practice

Volumn 69, Issue 7, 2015, Pages 729-737

  Hsu, C I ^a   Hsiao, F Y ^a,b   Wu, F L L ^a,b   Shen, L J ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST PLUS THIAZIDE DIURETIC AGENT; ANTIHYPERTENSIVE AGENT; CANDESARTAN; HYDROCHLOROTHIAZIDE; INDAPAMIDE; IRBESARTAN; LOSARTAN; METOLAZONE; OLMESARTAN; TELMISARTAN; THIAZIDE DIURETIC AGENT; TRICHLORMETHIAZIDE; UNCLASSIFIED DRUG; VALSARTAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DRUG DOSAGE FORM COMPARISON; FEMALE; HEALTH INSURANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MEDICATION POSSESSION RATIO; PHARMACOLOGICAL PARAMETERS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; TAIWAN; TREATMENT DURATION; BLOOD PRESSURE; CLINICAL TRIAL; COMBINATION DRUG THERAPY; DOSE RESPONSE; DRUG EFFECTS; DRUG UTILIZATION; FOLLOW UP; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME FACTOR; TREATMENT OUTCOME; TRENDS; YOUNG ADULT;

ADULT; AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; SODIUM CHLORIDE SYMPORTER INHIBITORS; SURVIVAL RATE; TAIWAN; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84933044515     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12591     Document Type: Article

References (25)

1. Members WG, Roger VL, Go AS, et al., Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012; 125: e2-220.
2. Bureau of Health Promotion Annual Report, 2007. http://health99.doh.gov.tw/article/ArticleDetail.aspx?TopIcNo=790&DS=1-life (accessed 7 May 2013).
3. Health Statistics in Taiwan, 2012. 2013. http://www.doh.gov.tw/CHT2006/DM/DM2-2.aspx?now-fod-list-no=9510&class-no=440&level-no=1 (accessed 7 May 2013).
4. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R,. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-13.
5. Wolf-Maier K, Cooper RS, Kramer H, et al., Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43: 10-7.
6. Su TC, Bai CH, Chang HY, et al., Evidence for improved control of hypertension in Taiwan: 1993-2002. J Hypertens 2008; 26: 600-6.
7. Wong MC, Tam WW, Cheung CS, et al., Drug adherence and the incidence of coronary heart disease- and stroke-specific mortality among 218,047 patients newly prescribed an antihypertensive medication: a five-year cohort study. Int J Cardiol 2013; 168: 928-33.
8. Mazzaglia G, Ambrosioni E, Alacqua M, et al., Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120: 1598-605.
9. Fitz-Simon N, Bennett K, Feely J,. A review of studies of adherence with antihypertensive drugs using prescription databases. Ther Clin Risk Manag 2005; 1: 93-106.
10. Chiang CE, Wang TD, Li YH, et al., 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension. J Formos Med Assoc 2010; 109: 740-73.
11. Hsu CN, Wang TD,. Secular trends in prescription patterns of single-pill combinations of an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker plus a thiazide diuretic for hypertensive patients in Taiwan. Acta Cardiol Sin 2013; 29: 49-55.
12. Yang W, Chang J, Kahler KH, et al., Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives. Curr Med Res Opin 2010; 26: 2065-76.
13. Malesker MA, Hilleman DE,. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy. Managed care (Langhorne, Pa) 2010; 19: 36-42.
14. Hilleman DE, Ryschon KL, Mohiuddin SM, Wurdeman RL,. Fixed-dose combination vs monotherapy in hypertension: a meta-analysis evaluation. J Hum Hypertens 1999; 13: 477-83.
15. Halpern MT, Khan ZM, Schmier JK, et al., Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension 2006; 47: 1039-48.
16. Elliott WJ,. Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. Journal of clinical hypertension (Greenwich, Conn) 2009; 11: 376-82.
17. Hsiao FY, Yang CL, Huang YT, Huang WF,. Using Taiwan's national health insurance research databases for pharmacoepidemiology research. Journal of Food and Drug analysis 2007; 15: 99.
18. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD,. Persistence with treatment for hypertension in actual practice. CMAJ 1999; 160: 31-7.
19. Cramer JA, Roy A, Burrell A, et al., Medication compliance and persistence: terminology and definitions. Value Health 2008; 11: 44-7.
20. Brixner DI, Jackson KC II, Sheng X, Nelson RE, Keskinaslan A,. Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations. Curr Med Res Opin 2008; 24: 2597-607.
21. Gupta AK, Arshad S, Poulter NR,. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010; 55: 399-407.
22. Burnier M,. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006; 19: 1190-6.
23. Hasford J, Schroder-Bernhardi D, Rottenkolber M, Kostev K, Dietlein G,. Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study. Eur J Clin Pharmacol 2007; 63: 1055-61.
24. Lee CY, Huang CC, Shih HC, Huang KH,. Factors influencing antihypertensive medication compliance in Taiwan: a nationwide population-based study. Eur J Prev Cardiol 2013; 20: 930-7.
25. Perreault S, Lamarre D, Blais L, et al., Persistence with treatment in newly treated middle-aged patients with essential hypertension. Ann Pharmacother 2005; 39: 1401-8.